Same Indication

Osimertinib vs Sitagliptin

Osimertinib vs Sitagliptin: Overview

This comparison examines the pharmacological differences between Osimertinib and Sitagliptin.

Mechanism of Action

Osimertinib: Third-generation irreversible EGFR TKI targeting T790M resistance mutation and activating mutations.

Sitagliptin: DPP-4 inhibitor increasing incretin levels.

Pharmacokinetics

Half-life: Osimertinib β€” 48 hours; Sitagliptin β€” 12.4 hours.

Chemical Properties

Molecular Formula: Osimertinib β€” C28H33N7O2; Sitagliptin β€” C16H15F6N5O.

Molecular Weight: Osimertinib β€” 499.6050 g/mol; Sitagliptin β€” 407.3140 g/mol.

Type: Osimertinib β€” Small molecule; Sitagliptin β€” Small molecule.